SCHEMBL3084012

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3082085	0.94	AR (0.48)	ARKMT2AMEN1GAABRD4
	SCHEMBL3079594	0.85	AR (0.43)	ARKMT2AMEN1GAAPGR
	SCHEMBL3081229	0.85	AR (0.50)	ARGAANSD2POLBCYP2C19
	SCHEMBL3075351	0.84	AR (0.47)	ARKMT2AMEN1GAABRD4
	SCHEMBL3083850	0.84	AR (0.46)	ARKMT2AMEN1GAABRD4
	SCHEMBL3076153	0.83	AR (0.47)	ARGAABRD4NSD2SLC22A12
	SCHEMBL3069848	0.83	AR (0.47)	ARKMT2AMEN1GAAMAPK1
	SCHEMBL3063842	0.83	AR (0.48)	ARGAANSD2POLBCYP2C19
	SCHEMBL3077443	0.82	AR (0.58)	ARKMT2AMEN1GAAMAPK1
	SCHEMBL3077518	0.82	AR (0.47)	ARKMT2AMEN1GAAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.